| 标题 |
 An open-label, randomized, multicenter, phase 3 study of trastuzumab deruxtecan with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy in HER2-expressing ovarian cancer: DESTINY-ovarian01 |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
GingerF
Nole
奔跑
Freud
潇洒的惋清
无极微光
初景
Viper
斯文的白玉
heekkll
cherry
呆萌的板栗
平淡的梦菲
七月流火
mafukairi
伶俐书芹
轻松骁
Mic
sunyz
皖公网安备34019202002308
